Search results
Results from the WOW.Com Content Network
Mhoira E.H. Leng (born 1963) FRSE MBChB MRCP(UK) FRCP(Ed and Glas) is one of the first Scottish specialists in palliative care, who has developed the palliative care services internationally, working in Eastern Europe, India and Africa and advises international institutions and agencies on palliative care in the developing world. [1]
The Liverpool Care Pathway for the Dying Patient (LCP) was a care pathway in the United Kingdom (excluding Wales) covering palliative care options for patients in the final days or hours of life. It was developed to help doctors and nurses provide quality end-of-life care , to transfer quality end-of-life care from the hospice to hospital setting.
The Scottish Intercollegiate Guidelines Network (SIGN) was formed in 1993 and develops and disseminates evidence based clinical practice guidelines. [7] These guidelines contain recommendations for effective practice based on current evidence. SIGN aim to improve the quality of health care for patients in Scotland.
The Patient Safety Commissioner for Scotland is a public office to provide scrutiny of care that is independent of both government and the health service.. The commissioner will "advocate for systemic improvement in the safety of health care, including forensic medical examinations, in Scotland and promote the importance of the views of patients and other members of the public in relation to ...
Palliative care got its start as hospice care delivered largely by caregivers at religious institutions. The first formal hospice was founded in 1948 by the British physician Dame Cicely Saunders in order to care for patients with terminal illnesses. [2] She defined key physical, emotional, social, and spiritual dimensions of distress in her work.
Hospice was the subject of the Netflix 2018 Academy Award–nominated [31] short documentary End Game, [32] about terminally ill patients in a San Francisco hospital and Zen Hospice Project, featuring the work of palliative care physician BJ Miller and other palliative care clinicians.
Greater care is recommended in those with heart problems. [12] It is an anticholinergic agent, [5] which does not have much effect on the brain. [13] Hyoscine butylbromide was patented in 1950, and approved for medical use in 1951. [14] It is on the World Health Organization's List of Essential Medicines. [15]
As hyoscyamine is a direct precursor in the plant biosynthesis of hyoscine, it is produced via the same metabolic pathway. [18] The biosynthesis of hyoscine begins with the decarboxylation of L-ornithine to putrescine by ornithine decarboxylase (EC 4.1.1.17). Putrescine is methylated to N-methylputrescine by putrescine N-methyltransferase (EC 2 ...